0001127602-21-003799.txt : 20210203
0001127602-21-003799.hdr.sgml : 20210203
20210203180544
ACCESSION NUMBER: 0001127602-21-003799
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lucchino David L.
CENTRAL INDEX KEY: 0001785288
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 21587717
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY, SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY, SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-02-01
0001703647
Frequency Therapeutics, Inc.
FREQ
0001785288
Lucchino David L.
C/O FREQUENCY THERAPEUTICS, INC.
19 PRESIDENTIAL WAY, 2ND FLOOR
WOBURN
MA
01801
1
1
President and CEO
Common Stock
2021-02-01
4
M
0
33102
.61
A
341188
D
Common Stock
2021-02-01
4
S
0
2900
41.2949
D
338288
D
Common Stock
2021-02-01
4
S
0
18600
42.8548
D
319688
D
Common Stock
2021-02-01
4
S
0
8900
43.7142
D
310788
D
Common Stock
2021-02-01
4
S
0
2702
44.5815
D
308086
D
Stock Option
.61
2021-02-01
4
M
0
33102
0
D
2028-05-21
Common Stock
33102
204549
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $40.87 to $41.695. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $42.2950 to $43.2800. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $43.3100 to $44.2400. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $44.4400 to $44.7250. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022.
/s/ Michael D. Bookman, Attorney-in-Fact for David L. Lucchino
2021-02-03